アンチセンス&RNAi治療薬市場レポート技術別(RNA干渉、アンチセンスRNA)、投与経路別(静脈内投与、皮下投与、髄腔内投与、肺投与、腹腔内投与、その他)、用途別(がん、心血管疾患(CVDs)、呼吸器疾患、腎疾患、神経変性疾患、遺伝子疾患、感染症、その他)、地域別 2025-2033年

アンチセンス&RNAi治療薬市場レポート技術別(RNA干渉、アンチセンスRNA)、投与経路別(静脈内投与、皮下投与、髄腔内投与、肺投与、腹腔内投与、その他)、用途別(がん、心血管疾患(CVDs)、呼吸器疾患、腎疾患、神経変性疾患、遺伝子疾患、感染症、その他)、地域別 2025-2033年

Report Format: PDF+Excel | Report ID: SR112024A25809
Buy Now

Language of the Report – English

ただし、追加料金で日本語のレポートが入手できる場合もある。

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Antisense & RNAi Therapeutics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Technology
    6.1    RNA Interference
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 siRNA
           6.1.2.2 miRNA
        6.1.3 Market Forecast
    6.2    Antisense RNA
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Route of Administration
    7.1    Intravenous Route
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Subcutaneous Route
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Intrathecal Route
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Pulmonary Delivery
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Intraperitoneal Injection
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Forecast
8   Market Breakup by Application
    8.1    Oncology
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Cardiovascular Diseases (CVDs)
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Respiratory Disorders
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Renal Diseases
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Neurodegenerative Disorders
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    Genetic Disorders
        8.6.1 Market Trends
        8.6.2 Market Forecast
    8.7    Infectious Diseases
        8.7.1 Market Trends
        8.7.2 Market Forecast
    8.8    Others
        8.8.1 Market Trends
        8.8.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Alnylam Pharmaceuticals Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Arbutus Biopharma Corporation
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Arrowhead Pharmaceuticals Inc.
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
        14.3.4    Benitec Biopharma Ltd.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Bio-Path Holdings Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
        14.3.6    Dicerna Pharmaceuticals Inc. (Novo Nordisk A/S)
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
        14.3.7    Ionis Pharmaceuticals Inc.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    OliX Pharmaceuticals Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
        14.3.9    Phio Pharmaceuticals Corp.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
        14.3.10    Sarepta Therapeutics Inc.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Silence Therapeutics
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
        14.3.12    Sirnaomics Inc.
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio

List of Figures

​Figure 1: Global: Antisense & RNAi Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Antisense & RNAi Therapeutics Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Antisense & RNAi Therapeutics Market: Breakup by Technology (in %), 2024
Figure 5: Global: Antisense & RNAi Therapeutics Market: Breakup by Route of Administration (in %), 2024
Figure 6: Global: Antisense & RNAi Therapeutics Market: Breakup by Application (in %), 2024
Figure 7: Global: Antisense & RNAi Therapeutics Market: Breakup by Region (in %), 2024
Figure 8: Global: Antisense & RNAi Therapeutics (RNA Interference) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Antisense & RNAi Therapeutics (RNA Interference) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Antisense & RNAi Therapeutics (Antisense RNA) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Antisense & RNAi Therapeutics (Antisense RNA) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Antisense & RNAi Therapeutics (Intravenous Route) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Antisense & RNAi Therapeutics (Intravenous Route) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Antisense & RNAi Therapeutics (Subcutaneous Route) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Antisense & RNAi Therapeutics (Subcutaneous Route) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Antisense & RNAi Therapeutics (Intrathecal Route) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Antisense & RNAi Therapeutics (Intrathecal Route) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Antisense & RNAi Therapeutics (Pulmonary Delivery) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Antisense & RNAi Therapeutics (Pulmonary Delivery) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Antisense & RNAi Therapeutics (Intraperitoneal Injection) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Antisense & RNAi Therapeutics (Intraperitoneal Injection) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Antisense & RNAi Therapeutics (Other Routes of Administration) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Antisense & RNAi Therapeutics (Other Routes of Administration) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Antisense & RNAi Therapeutics (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Antisense & RNAi Therapeutics (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Antisense & RNAi Therapeutics (Cardiovascular Diseases (CVDs)) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Antisense & RNAi Therapeutics (Cardiovascular Diseases (CVDs)) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Antisense & RNAi Therapeutics (Respiratory Disorders) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Antisense & RNAi Therapeutics (Respiratory Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Antisense & RNAi Therapeutics (Renal Diseases) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Antisense & RNAi Therapeutics (Renal Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Global: Antisense & RNAi Therapeutics (Neurodegenerative Disorders) Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Global: Antisense & RNAi Therapeutics (Neurodegenerative Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Global: Antisense & RNAi Therapeutics (Genetic Disorders) Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Global: Antisense & RNAi Therapeutics (Genetic Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Global: Antisense & RNAi Therapeutics (Infectious Diseases) Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Global: Antisense & RNAi Therapeutics (Infectious Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Global: Antisense & RNAi Therapeutics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Global: Antisense & RNAi Therapeutics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: North America: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: North America: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: United States: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: United States: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Canada: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Canada: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Asia-Pacific: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Asia-Pacific: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: China: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: China: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Japan: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Japan: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: India: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: India: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: South Korea: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: South Korea: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Australia: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Australia: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Indonesia: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Indonesia: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Others: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Others: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Europe: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Europe: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Germany: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Germany: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: France: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: France: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: United Kingdom: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: United Kingdom: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Italy: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Italy: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Spain: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Spain: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Russia: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Russia: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Others: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Others: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Latin America: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Latin America: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 80: Brazil: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 81: Brazil: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 82: Mexico: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 83: Mexico: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 84: Others: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 85: Others: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 86: Middle East and Africa: Antisense & RNAi Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 87: Middle East and Africa: Antisense & RNAi Therapeutics Market: Breakup by Country (in %), 2024
Figure 88: Middle East and Africa: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 89: Global: Antisense & RNAi Therapeutics Industry: SWOT Analysis
Figure 90: Global: Antisense & RNAi Therapeutics Industry: Value Chain Analysis
Figure 91: Global: Antisense & RNAi Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Antisense & RNAi Therapeutics Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Antisense & RNAi Therapeutics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
Table 3: Global: Antisense & RNAi Therapeutics Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
Table 4: Global: Antisense & RNAi Therapeutics Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 5: Global: Antisense & RNAi Therapeutics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Antisense & RNAi Therapeutics Market: Competitive Structure
Table 7: Global: Antisense & RNAi Therapeutics Market: Key Players

アンチセンス&RNAi治療薬市場レポート技術別(RNA干渉、アンチセンスRNA)、投与経路別(静脈内投与、皮下投与、髄腔内投与、肺投与、腹腔内投与、その他)、用途別(がん、心血管疾患(CVDs)、呼吸器疾患、腎疾患、神経変性疾患、遺伝子疾患、感染症、その他)、地域別 2025-2033年
Purchase Options Year End sale




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARATI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More
DEinternational Egypt

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

Read More
Gulf Excellent Group

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Read More
FS Corporation Inc.

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

Read More
Egyptian Industrial Investment Group

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

Read More
Vishnu Chemicals

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

Read More
MOUNT EVEREST BREWERIES LIMITED

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

Read More
Borges Branded Foods

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

Read More
Godrej Consumer Products Limited

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

Read More
ADC Therapeutics

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

Read More
Ivanti

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

Read More
Asiatic Electrical & Switchgear P. Ltd.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Read More
Denka Co., Ltd.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.

Read More